Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

25%

Ph early_phase_1

25%

Ph phase_2

25%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Early Phase 1First-in-human

1(25.0%)

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(2)

Detailed Status

Completed2

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (25.0%)

Phase 11 (25.0%)

Phase 21 (25.0%)

N/A1 (25.0%)

Trials by Status

terminated125%

completed250%

withdrawn125%

Recent Activity

0 active trials

Showing 4 of 4

withdrawnearly_phase_1

Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients

NCT04246151

terminatedphase_2

Clinical Trials (4)

Showing 4 of 4 trials

NCT04246151Early Phase 1

Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients

Withdrawn

NCT01605747Phase 2

Study of Culturelle in the Prophylaxis of Infection and Diarrhea

Terminated

NCT00748748Phase 1

Effect of Lactobacillus Probiotic on Healthy Adults

Completed

NCT00282113Not Applicable

Effects of Probiotic and Prebiotic Combinations on Premature Infants

Completed

All 4 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 4